178138 Health-related quality of life and success in chronic disease prevention programs

Sunday, October 26, 2008

Cynthia J. Brown, PhD , Office of Graduate Studies and Academic Centers, University of Texas-Pan American, Edinburg, TX
José A. Pagán, PhD , Department of Health Management and Policy, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX
Suad F. Ghaddar, PhD , South Texas Border Health Disparities Center, University of Texas-Pan American, Edinburg, TX
The objective of this research is to assess whether participation in community-based chronic disease prevention programs and success at enhancing one's clinical outcomes can help determine health-related quality of life (HRQOL) among the largely Hispanic population residing in US-Mexico border communities.

The data used is based on 1200+ participants in Alliance for a Healthy Border, a diabetes and cardiovascular disease prevention program sponsored by Pfizer Inc. The initiative funds nutrition and physical activity education at 12 federally-qualified community health centers located along the US-Mexico border. After adjusting for age, gender, smoking, employment, physical activity, and chronic health conditions (diabetes, hypertension), among others, participants who were successful at reducing their BMI and their HbA1C levels at program end were more likely to report better quality of life. Compared with participants who were unsuccessful at reducing these levels, odds ratios (ORs) for reporting 14 days or more of poor physical health during the past 30 days was 0.54 (95% confidence interval (CI): 0.34-0.87) for those who reduced their BMI and 0.51 (95% CI: 0.31-0.82) for those who reduced their HbA1C. Corresponding ORs for reporting 14 days or more of poor mental health were 0.62 (95% CI: 0.4-0.97) and 0.55 (95% CI: 0.35-0.85). ORs for reporting 14 or more activity limitation days were 0.44 (95% CI: 0.23-0.85) for those successful at reducing their HbA1C levels.

The results highlight the importance of partnerships between the private and public health sectors, and of the adoption of community-based, culturally appropriate approaches to health education.

Learning Objectives:
1. Describe Pfizer’s Alliance for a Healthy Border (AHB), a diabetes and cardiovascular disease prevention program that targets the high incidence of diabetes and heart disease among the largely Hispanic population residing in US-Mexico border communities. 2. Analyze the different determinants of health-related quality of life (HRQOL) measures. 3. Assess whether participation and success at improving clinical outcomes among AHB participants can help determine HRQOL measures.

Keywords: Quality of Life, Disease Prevention

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked in the development and methodology of the alliance for a healthy border.
Any relevant financial relationships? Yes

Name of Organization Clinical/Research Area Type of relationship
Pfizer Inc Health Management Independent Contractor (contracted research and clinical trials)

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.